Picture of Qiagen NV logo

QGEN Qiagen NV News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapNeutral

Brief: Qiagen Exceeds Outlook For Q4 2023, Led By 8% CER Sales Growth In Non-Covid Products And Improved Operational Profitability

Feb 6 (Reuters) - Qiagen Nv  QIA.DE :
    * QIAGEN EXCEEDS OUTLOOK FOR Q4 2023, LED BY 8% CER SALES
GROWTH
IN NON-COVID PRODUCTS AND IMPROVED OPERATIONAL PROFITABILITY
    * SEES 2024 NET SALES OF AT LEAST $2.0 BILLION CER
    * TOTAL SALES FOR Q4 2023 ROSE 2% (+1% CER) TO $509 MILLION
FROM
Q4 2022
    * 2024 ADJUSTED DILUTED EPS EXPECTED TO BE AT LEAST $2.10
CER
    * SIGNIFICANT PRESSURE EXPECTED ON NON-OPERATING INCOME FOR
FY
2024 DUE TO ANTICIPATED LOWER INTEREST INCOME & HIGHER TAX RATE
VERSUS 2023
    * FULL-YEAR 2023 SALES DECLINED 8% TO $1.97 BILLION
    * QTRLY ADJUSTED DILUTED EARNINGS PER SHARE WERE $0.55 CER
    * FY 2023 ADJUSTED DILUTED EPS WERE $2.09 CER AND EXCEEDED
OUTLOOK
FOR AT LEAST $2.07 CER

Source text for Eikon:  ID:nGNX40ZksC 
Further company coverage:  QIA.DE 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Qiagen NV

See all news